REWARDS (Registry Experience at the Washington Hospital Center, DES - Xience V).
Active, no longer recruiting
Phase of Trial: Phase IV
Latest Information Update: 27 Sep 2016
At a glance
- Drugs Everolimus (Primary)
- Indications Coronary artery disease; Coronary artery restenosis
- Focus Therapeutic Use
- Acronyms REWARDS-XV
- 28 Mar 2013 Planned End Date changed from 1 Jun 2012 to 1 Sep 2013 as reported by ClinicalTrials.gov.
- 28 Mar 2013 Status changed from recruiting to active, no longer recruiting as reported by ClinicalTrials.gov.
- 24 Apr 2012 Planned end date changed from 1 Aug 2011 to 1 Jun 2012 as reported by ClinicalTrials.gov.